September 02, 2025 Bile Acid Biomarker Stratifies HBV Cirrhosis Antiviral therapy lowers taurochenodeoxycholic acid concentrations in patients with hepatitis B virus cirrhosis, reflecting changes in bile acid balance with viral suppression. Conexiant
August 21, 2025 Metabolic Diseases Weaken Hepatitis B Treatment Response The number of metabolic conditions may shape outcomes in hepatitis B therapy. Conexiant
August 11, 2025 FDA OKs Bioequivalent Iron Sucrose for CKD Anemia The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease. Conexiant
July 17, 2025 Metformin Ineffective for COVID Recovery, Trial Finds Researchers found metformin did not significantly shorten COVID-19 symptom duration in low-risk outpatients, though it was safe and well tolerated. Conexiant
June 24, 2025 Shorter Antibiotic Courses: Safe for DFO? A new meta-analysis aims to clarify optimal antibiotic duration for diabetic foot osteomyelitis Conexiant